ATE473970T1 - N-substituiertes benzothiophensulfonamidderivat - Google Patents

N-substituiertes benzothiophensulfonamidderivat

Info

Publication number
ATE473970T1
ATE473970T1 AT03712691T AT03712691T ATE473970T1 AT E473970 T1 ATE473970 T1 AT E473970T1 AT 03712691 T AT03712691 T AT 03712691T AT 03712691 T AT03712691 T AT 03712691T AT E473970 T1 ATE473970 T1 AT E473970T1
Authority
AT
Austria
Prior art keywords
substituted benzothiophenesulfonamide
derivative
benzothiophenesulfonamide derivative
substituted
chymase
Prior art date
Application number
AT03712691T
Other languages
English (en)
Inventor
Shoji Satoh
Yusuke Mizuno
Hidekazu Masaki
Original Assignee
Toa Eiyo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toa Eiyo Ltd filed Critical Toa Eiyo Ltd
Application granted granted Critical
Publication of ATE473970T1 publication Critical patent/ATE473970T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT03712691T 2002-03-15 2003-03-13 N-substituiertes benzothiophensulfonamidderivat ATE473970T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002072307 2002-03-15
PCT/JP2003/003023 WO2003078419A1 (fr) 2002-03-15 2003-03-13 Derive du benzothiophenesulfonamide substitue en n

Publications (1)

Publication Number Publication Date
ATE473970T1 true ATE473970T1 (de) 2010-07-15

Family

ID=28035161

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03712691T ATE473970T1 (de) 2002-03-15 2003-03-13 N-substituiertes benzothiophensulfonamidderivat

Country Status (6)

Country Link
EP (1) EP1486494B1 (de)
JP (1) JP4452809B2 (de)
AT (1) ATE473970T1 (de)
CA (1) CA2479353C (de)
DE (1) DE60333351D1 (de)
WO (1) WO2003078419A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003335670A (ja) * 2002-03-15 2003-11-25 Toa Eiyo Ltd 癒着防止剤
CN101160290B (zh) 2004-12-02 2011-01-19 第一三共株式会社 7-元环化合物、其制备方法和药物用途
AU2007268507B2 (en) 2006-05-31 2012-01-19 Daiichi Sankyo Company, Limited Seven-membered ring compound, production method thereof and pharmaceutical use thereof
BRPI0718167A2 (pt) * 2006-10-18 2013-11-26 Janssen Pharmaceutica Nv Inibidores de quimase
BRPI0806542A2 (pt) 2007-01-10 2014-04-22 Hoffmann La Roche Derivados de sulfonamida como inibidores de quimase
SG181883A1 (en) 2009-12-25 2012-08-30 Daiichi Sankyo Co Ltd Seven-membered ring compound and pharmaceutical use therefor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE243203T1 (de) * 1995-04-04 2003-07-15 Texas Biotechnology Corp Thienyl-, furyl-, pyrrolyl- und biphenylsulfonamide und derivate zur modulation der endothelin-aktivität
DE69622148T2 (de) * 1995-09-28 2002-10-31 Suntory Limited, Osaka Chinazozin derivate und deren verwendung
GB9803411D0 (en) * 1998-02-18 1998-04-15 Smithkline Beecham Plc Novel compounds
JP2000095770A (ja) * 1998-07-22 2000-04-04 Toa Eiyo Ltd Ｎ置換チアゾリジン誘導体及びそれを含有する医薬
GB9818914D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Use
JP4491866B2 (ja) * 1999-09-30 2010-06-30 三菱化学株式会社 アシルスルホンアミド誘導体
CN1245400C (zh) * 2000-09-18 2006-03-15 东亚荣养株式会社 N－取代苯并噻唑磺胺衍生物

Also Published As

Publication number Publication date
EP1486494B1 (de) 2010-07-14
CA2479353A1 (en) 2003-09-25
EP1486494A1 (de) 2004-12-15
DE60333351D1 (de) 2010-08-26
JPWO2003078419A1 (ja) 2005-07-14
WO2003078419A1 (fr) 2003-09-25
JP4452809B2 (ja) 2010-04-21
EP1486494A4 (de) 2006-03-29
CA2479353C (en) 2010-09-14

Similar Documents

Publication Publication Date Title
HUS1600055I1 (hu) Béta-laktamáz-inhibitor aktivitással rendelkezõ új heterociklusos vegyületek
IS7729A (is) Bensónaþýridín með PDE 3/4 tálmunarvirkni
AU2003257822A1 (en) Heterocyclic compound having hiv integrase inhibitory activity
NO20060538L (no) Pyrrolopyrimidinonderivater
EP1600457A4 (de) Peptidderivate mit beta-sekretase-hemmender wirkung
DE60336377D1 (de) Audiosystem auf der basis von eigenstrahlen mindestens zweiter ordnung
AU2003209060A1 (en) Assay for acytyltransferase or deacetylase activity
NO20053150D0 (no) System for administrasjon av medisin.
ATE304015T1 (de) Triaryl-oxy-aryl-spiro-pyrimidin-2, 4, 6-trion metalloproteinase inhibitoren
WO2004009616A3 (en) Ghrelin analogs
DE60304254D1 (de) Zielführungssystem basiert auf visueller Tätigkeit des Fahrers
NO20052487D0 (no) 1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater.
AP2004003156A0 (en) Peptide deformylase inhibitors.
MXPA03009413A (es) Cartucho de disco.
ATE473970T1 (de) N-substituiertes benzothiophensulfonamidderivat
AP2004003190A0 (en) Broaspectrum substituted benzisoxazole sulfonamideHIV protease inhibitors.
DK1487802T3 (da) 2,3-diaryl-pyrazolidin-derivater som neurotensin-nedbrydende enzyminhibitorer
ATE491709T1 (de) Pyrrolidinohydrochinazoline
WO2003082837A1 (en) Hydroxymorpholinone derivative and medicinal use thereof
ITTO20020217U1 (it) Gioiello anulare.
ES1053443Y (es) Pijama perfeccionado.
FI20030231A0 (fi) Läpiviennin palusuojausmenetelmä, läpivientiasetelma sekä asennuskappale sen asentamiseksi
ITBO20030786A1 (it) Contenitore frangibile per attivita' ludica.
ITRM20030014A0 (it) Procedimenti di inibizione dell'attivita' enzimatica e relative applicazioni industriali.
AU2003201663A1 (en) Enzyme substrates for the determination of activity of staphylococcus sp. extracellular protease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties